Gamma delta T cells: a rising star in cancer therapy
Drug Target Review
FEBRUARY 28, 2024
Prior to the founding of IN8bio, from 2014 to 2017, Mr Ho was the Founder and Managing Partner at AlephPoint Capital, a private healthcare investment fund. Regulation of cutaneous malignancy by gammadelta T cells. Mr Ho has worked in the biotechnology industry for almost 20 years. References Fichtner A, Ravens S, Prinz I.
Let's personalize your content